Yoshifumi Sonobe to Encephalomyelitis, Autoimmune, Experimental
This is a "connection" page, showing publications Yoshifumi Sonobe has written about Encephalomyelitis, Autoimmune, Experimental.
Connection Strength
1.105
-
Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J Immunol. 2012 Mar 15; 188(6):2602-11.
Score: 0.413
-
Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J Exp Med. 2007 Dec; 213(4):329-39.
Score: 0.309
-
The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells. J Neuroimmunol. 2011 Dec 15; 240-241:58-64.
Score: 0.101
-
Phenytoin at optimum doses ameliorates experimental autoimmune encephalomyelitis via modulation of immunoregulatory cells. J Neuroimmunol. 2011 Apr; 233(1-2):112-9.
Score: 0.096
-
Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. Tohoku J Exp Med. 2009 Feb; 217(2):87-92.
Score: 0.084
-
Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A. 2008 Mar 11; 105(10):3915-20.
Score: 0.079
-
IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol. 2011 Apr 01; 186(7):4415-21.
Score: 0.024